{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:56:03Z","timestamp":1762955763231,"version":"3.41.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T00:00:00Z","timestamp":1505174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1038\/mp.2017.176","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T08:01:28Z","timestamp":1505203288000},"page":"1673-1679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["G\u03b2\u03b3 subunit activation promotes dopamine efflux through the dopamine transporter"],"prefix":"10.1038","volume":"22","author":[{"given":"J","family":"Garcia-Olivares","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Baust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S G","family":"Amara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G E","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,12]]},"reference":[{"key":"BFmp2017176_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrn1008","volume":"4","author":"GE Torres","year":"2003","unstructured":"Torres GE, Gainetdinov RR, Caron MG . Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 2003; 4: 13\u201325.","journal-title":"Nat Rev Neurosci"},{"key":"BFmp2017176_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.tins.2004.03.011","volume":"27","author":"SJ Cragg","year":"2004","unstructured":"Cragg SJ, Rice ME . DAncing past the DAT at a DA synapse. Trends Neurosci 2004; 27: 270\u2013277.","journal-title":"Trends Neurosci"},{"key":"BFmp2017176_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0165-6147(93)90029-J","volume":"14","author":"B Giros","year":"1993","unstructured":"Giros B, Caron MG . Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 1993; 14: 43\u201349.","journal-title":"Trends Pharmacol Sci"},{"key":"BFmp2017176_CR4","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","volume":"75","author":"D Sulzer","year":"2005","unstructured":"Sulzer D, Sonders MS, Poulsen NW, Galli A . Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005; 75: 406\u2013433.","journal-title":"Prog Neurobiol"},{"key":"BFmp2017176_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/19208","volume":"398","author":"TW Robbins","year":"1999","unstructured":"Robbins TW, Everitt BJ . Drug addiction: bad habits add up. Nature 1999; 398: 567\u2013570.","journal-title":"Nature"},{"key":"BFmp2017176_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0376-8716(98)00068-4","volume":"51","author":"SG Amara","year":"1998","unstructured":"Amara SG, Sonders MS . Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend 1998; 51: 87\u201396.","journal-title":"Drug Alcohol Depend"},{"key":"BFmp2017176_CR7","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1021\/bi200405c","volume":"50","author":"JJ Sager","year":"2011","unstructured":"Sager JJ, Torres GE . Proteins interacting with monoamine transporters: current state and future challenges. Biochemistry 2011; 50: 7295\u20137310.","journal-title":"Biochemistry"},{"key":"BFmp2017176_CR8","doi-asserted-by":"publisher","first-page":"29627","DOI":"10.1074\/jbc.M112.367219","volume":"287","author":"T Steinkellner","year":"2012","unstructured":"Steinkellner T, Yang JW, Montgomery TR, Chen WQ, Winkler MT, Sucic S et al. Ca(2+)\/calmodulin-dependent protein kinase IIalpha (alphaCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J Biol Chem 2012; 287: 29627\u201329635.","journal-title":"J Biol Chem"},{"key":"BFmp2017176_CR9","doi-asserted-by":"publisher","first-page":"40442","DOI":"10.1074\/jbc.M501969200","volume":"280","author":"MA Cervinski","year":"2005","unstructured":"Cervinski MA, Foster JD, Vaughan RA . Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms. J Biol Chem 2005; 280: 40442\u201340449.","journal-title":"J Biol Chem"},{"key":"BFmp2017176_CR10","doi-asserted-by":"publisher","first-page":"e59788","DOI":"10.1371\/journal.pone.0059788","volume":"8","author":"J Garcia-Olivares","year":"2013","unstructured":"Garcia-Olivares J, Torres-Salazar D, Owens WA, Baust T, Siderovski DP, Amara SG et al. Inhibition of dopamine transporter activity by G protein betagamma subunits. PLoS ONE 2013; 8: e59788.","journal-title":"PLoS ONE"},{"key":"BFmp2017176_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1471-4159.2011.07335.x","volume":"118","author":"V Leviel","year":"2011","unstructured":"Leviel V . Dopamine release mediated by the dopamine transporter, facts and consequences. J Neurochem 2011; 118: 475\u2013489.","journal-title":"J Neurochem"},{"key":"BFmp2017176_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1098\/rstb.2014.0185","volume":"370","author":"ME Rice","year":"2015","unstructured":"Rice ME, Patel JC . Somatodendritic dopamine release: recent mechanistic insights. Philos Trans R Soc Lond B Biol Sci 2015; 370: 1\u201314.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFmp2017176_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tips.2014.11.006","volume":"36","author":"HH Sitte","year":"2015","unstructured":"Sitte HH, Freissmuth M . Amphetamines, new psychoactive drugs and the monoamine transporter cycle. Trends Pharmacol Sci 2015; 36: 41\u201350.","journal-title":"Trends Pharmacol Sci"},{"key":"BFmp2017176_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nchembio.1545","volume":"10","author":"PJ Hamilton","year":"2014","unstructured":"Hamilton PJ, Belovich AN, Khelashvili G, Saunders C, Erreger K, Javitch JA et al. PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein. Nat Chem Biol 2014; 10: 582\u2013589.","journal-title":"Nat Chem Biol"},{"key":"BFmp2017176_CR15","doi-asserted-by":"publisher","first-page":"19634","DOI":"10.1074\/jbc.M300052200","volume":"278","author":"F Goubaeva","year":"2003","unstructured":"Goubaeva F, Ghosh M, Malik S, Yang J, Hinkle PM, Griendling KK et al. Stimulation of cellular signaling and G protein subunit dissociation by G protein betagamma subunit-binding peptides. J Biol Chem 2003; 278: 19634\u201319641.","journal-title":"J Biol Chem"},{"key":"BFmp2017176_CR16","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1073\/pnas.1418605112","volume":"112","author":"JB Stott","year":"2015","unstructured":"Stott JB, Povstyan OV, Carr G, Barrese V, Greenwood IA . G-protein betagamma subunits are positive regulators of Kv7.4 and native vascular Kv7 channel activity. Proc Natl Acad Sci USA 2015; 112: 6497\u20136502.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2017176_CR17","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1523\/JNEUROSCI.5346-06.2007","volume":"27","author":"YF Wang","year":"2007","unstructured":"Wang YF, Hatton GI . Dominant role of betagamma subunits of G-proteins in oxytocin-evoked burst firing. J Neurosci 2007; 27: 1902\u20131912.","journal-title":"J Neurosci"},{"key":"BFmp2017176_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1124\/mol.107.041780","volume":"73","author":"DM Lehmann","year":"2008","unstructured":"Lehmann DM, Seneviratne AM, Smrcka AV . Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation. Mol Pharmacol 2008; 73: 410\u2013418.","journal-title":"Mol Pharmacol"},{"key":"BFmp2017176_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/emboj\/20.4.767","volume":"20","author":"JK Scott","year":"2001","unstructured":"Scott JK, Huang SF, Gangadhar BP, Samoriski GM, Clapp P, Gross RA et al. Evidence that a protein-protein interaction 'hot spot' on heterotrimeric G protein betagamma subunits is used for recognition of a subclass of effectors. EMBO J 2001; 20: 767\u2013776.","journal-title":"EMBO J"},{"key":"BFmp2017176_CR20","doi-asserted-by":"publisher","first-page":"16946","DOI":"10.1074\/jbc.273.27.16946","volume":"273","author":"G Krapivinsky","year":"1998","unstructured":"Krapivinsky G, Kennedy ME, Nemec J, Medina I, Krapivinsky L, Clapham DE . Gbeta binding to GIRK4 subunit is critical for G protein-gated K+ channel activation. J Biol Chem 1998; 273: 16946\u201316952.","journal-title":"J Biol Chem"},{"key":"BFmp2017176_CR21","first-page":"1124","volume":"10","author":"Y Lin","year":"2011","unstructured":"Lin Y, Smrcka AV . Understanding Molecular Recognition by G protein {beta}{gamma} Subunits on the Path to Pharmacological Targeting. Mol Pharmacol 2011; 10: 1124, \/mol.111.073072.","journal-title":"Mol Pharmacol"},{"key":"BFmp2017176_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/j.1471-4159.2010.06788.x","volume":"114","author":"F Opazo","year":"2010","unstructured":"Opazo F, Schulz JB, Falkenburger BH . PKC links Gq-coupled receptors to DAT-mediated dopamine release. J Neurochem 2010; 114: 587\u2013596.","journal-title":"J Neurochem"},{"key":"BFmp2017176_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros B, Jaber M, Jones SR, Wightman RM, Caron MG . Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996; 379: 606\u2013612.","journal-title":"Nature"},{"key":"BFmp2017176_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.neuron.2011.02.010","volume":"69","author":"D Sulzer","year":"2011","unstructured":"Sulzer D . How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 2011; 69: 628\u2013649.","journal-title":"Neuron"},{"key":"BFmp2017176_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/0896-6273(93)90145-H","volume":"11","author":"D Attwell","year":"1993","unstructured":"Attwell D, Barbour B, Szatkowski M . Nonvesicular release of neurotransmitter. Neuron 1993; 11: 401\u2013407.","journal-title":"Neuron"},{"key":"BFmp2017176_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1124\/jpet.111.191056","volume":"346","author":"KC Schmitt","year":"2013","unstructured":"Schmitt KC, Rothman RB, Reith ME . Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates. J Pharmacol Exp Ther 2013; 346: 2\u201310.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2017176_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-3565(25)31549-1","volume":"208","author":"JF Fischer","year":"1979","unstructured":"Fischer JF, Cho AK . Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 1979; 208: 203\u2013209.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2017176_CR28","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1124\/mol.56.5.1047","volume":"56","author":"C Pifl","year":"1999","unstructured":"Pifl C, Singer EA . Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Mol Pharmacol 1999; 56: 1047\u20131054.","journal-title":"Mol Pharmacol"},{"key":"BFmp2017176_CR29","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1046\/j.1471-4159.1998.71031289.x","volume":"71","author":"HH Sitte","year":"1998","unstructured":"Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C . Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 1998; 71: 1289\u20131297.","journal-title":"J Neurochem"},{"key":"BFmp2017176_CR30","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1073\/pnas.0407737102","volume":"102","author":"KM Kahlig","year":"2005","unstructured":"Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA et al. Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci USA 2005; 102: 3495\u20133500.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFmp2017176_CR31","doi-asserted-by":"publisher","first-page":"12070","DOI":"10.1074\/jbc.M212815200","volume":"278","author":"H Khoshbouei","year":"2003","unstructured":"Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A . Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependent mechanism. J Biol Chem 2003; 278: 12070\u201312077.","journal-title":"J Biol Chem"},{"key":"BFmp2017176_CR32","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1371\/journal.pbio.0020078","volume":"2","author":"H Khoshbouei","year":"2004","unstructured":"Khoshbouei H, Sen N, Guptaroy B, Johnson L, Lund D, Gnegy ME et al. N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol 2004; 2: E78.","journal-title":"PLoS Biol"},{"key":"BFmp2017176_CR33","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.neuron.2006.06.028","volume":"51","author":"JU Fog","year":"2006","unstructured":"Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N et al. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 2006; 51: 417\u2013429.","journal-title":"Neuron"},{"key":"BFmp2017176_CR34","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1523\/JNEUROSCI.17-15-05738.1997","volume":"17","author":"SJ Cragg","year":"1997","unstructured":"Cragg SJ, Greenfield SA . Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci 1997; 17: 5738\u20135746.","journal-title":"J Neurosci"},{"key":"BFmp2017176_CR35","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1126\/science.1060645","volume":"293","author":"BH Falkenburger","year":"2001","unstructured":"Falkenburger BH, Barstow KL, Mintz IM . Dendrodendritic inhibition through reversal of dopamine transport. Science 2001; 293: 2465\u20132470.","journal-title":"Science"},{"key":"BFmp2017176_CR36","doi-asserted-by":"publisher","first-page":"7040","DOI":"10.1523\/JNEUROSCI.0473-08.2008","volume":"28","author":"MS Mazei-Robison","year":"2008","unstructured":"Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH et al. Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci 2008; 28: 7040\u20137046.","journal-title":"J Neurosci"},{"key":"BFmp2017176_CR37","doi-asserted-by":"publisher","first-page":"E4779","DOI":"10.1073\/pnas.1417294111","volume":"111","author":"MA Mergy","year":"2014","unstructured":"Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL et al. The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Proc Natl Acad Sci USA 2014; 111: E4779\u2013E4788.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2017176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2017176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/mp.2017.176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/mp2017176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T18:06:37Z","timestamp":1750874797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2017176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["BFmp2017176"],"URL":"https:\/\/doi.org\/10.1038\/mp.2017.176","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"type":"print","value":"1359-4184"},{"type":"electronic","value":"1476-5578"}],"subject":[],"published":{"date-parts":[[2017,9,12]]},"assertion":[{"value":"11 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}